Rising cases of non‑CF bronchiectasis and advancements in inhalation therapies and diagnostic imaging are driving market expansion, with clinics and pulmonology centers adopting new pharmacologic and device-based solutions. https://www.datamintelligence.com/research-report/non-cystic-fibrosis-bronchiectasis-treatment-market